Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Zur Rose Group AG
  6. Summary
    ROSE   CH0042615283

ZUR ROSE GROUP AG

(ROSE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
10/15/2021 10/18/2021 10/19/2021 10/20/2021 10/21/2021 Date
369(c) 369.5(c) 379.5(c) 390(c) 360(c) Last
45 981 37 714 40 540 90 041 128 780 Volume
+0.82% +0.14% +2.71% +2.77% -7.69% Change
More quotes
Estimated financial data (e)
Sales 2021 1 722 M 1 875 M 1 875 M
Net income 2021 -154 M -167 M -167 M
Net Debt 2021 383 M 417 M 417 M
P/E ratio 2021 -23,1x
Yield 2021 -
Sales 2022 2 502 M 2 726 M 2 726 M
Net income 2022 -92,6 M -101 M -101 M
Net Debt 2022 469 M 511 M 511 M
P/E ratio 2022 -48,5x
Yield 2022 -
Capitalization 3 450 M 3 759 M 3 758 M
EV / Sales 2021 2,23x
EV / Sales 2022 1,57x
Nbr of Employees 1 960
Free-Float 88,2%
More Financials
Company
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and... 
More about the company
Ratings of Zur Rose Group AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about ZUR ROSE GROUP AG
10/21ZUR ROSE GROUP : Jefferies reiterates its Buy rating
MD
10/21ZUR ROSE : CEO To Take Over Chair's Role, Appoints New CEO
MT
10/21ZUR ROSE : Revenue Grows 18% in First Nine Months of 2021; FY21 Revenue Growth Guidance Do..
MT
10/21ZUR ROSE : continues to grow strongly Ad hoc announcement pursuant to Art. 53 LR
PU
10/21ZUR ROSE GROUP : Board of Directors nominates Walter Oberhänsli as Chairman and appoints W..
PU
10/21ZUR ROSE GROUP : Board of Directors nominates Walter Oberhänsli as Chairman and appoints W..
DJ
10/21Zur Rose Group continues to grow strongly
DJ
10/21Zur Rose Group continues to grow -2-
DJ
10/08ZUR ROSE : Berenberg Downgrades Recommendation on Zur Rose Group to Hold From Buy, Maintai..
MT
10/08ZUR ROSE GROUP : Berenberg gives a Neutral rating
MD
10/01ZUR ROSE GROUP : UBS reiterates its Sell rating
MD
09/30ZUR ROSE GROUP : Baader Bank reiterates its Buy rating
MD
09/21ZUR ROSE GROUP : UBS reaffirms its Sell rating
MD
08/30ZUR ROSE GROUP : Jefferies maintains a Buy rating
MD
08/25ZUR ROSE GROUP : UBS reiterates its Sell rating
MD
More news
News in other languages on ZUR ROSE GROUP AG
10/21AKTIEN EUROPA SCHLUSS : Angezählte Evergrande bremst die Börsen
10/21MÄRKTE EUROPA/Evergrande drückt - ABB mit Lieferketten-Problemen
10/21AKTIEN SCHWEIZ SCHLUSS : SMI dank Schwergewichten erneut über 12'000 Punkten
10/21BOURSE ZURICH : le SMI termine confortablement au-dessus des 12'000 points
10/21XETRA-SCHLUSS/Etwas leichter - SAP unter Druck
More news
Analyst Recommendations on ZUR ROSE GROUP AG
More recommendations
Chart ZUR ROSE GROUP AG
Duration : Period :
Zur Rose Group AG Technical Analysis Chart | ROSE | CH0042615283 | MarketScreener
Technical analysis trends ZUR ROSE GROUP AG
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 360,00 CHF
Average target price 464,67 CHF
Spread / Average Target 29,1%
EPS Revisions
Managers and Directors
Walter Oberhänsli Chief Executive Officer & Executive Director
Marcel Ziwica Chief Financial Officer
Stefan Feuerstein Chairman
Madhu Nutakki Chief Technology Officer
Bernd Michael Gschaider Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZUR ROSE GROUP AG27.21%3 759
WALGREENS BOOTS ALLIANCE, INC.23.22%41 887
JD HEALTH INTERNATIONAL INC.-48.63%32 479
MCKESSON CORPORATION19.13%31 877
CARDINAL HEALTH, INC.-8.03%13 978
HUADONG MEDICINE CO., LTD26.77%9 399